Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
Open Access
- 15 August 2013
- journal article
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (16) , 2519-2520
Abstract
(2013). Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy. Cell Cycle: Vol. 12, No. 16, pp. 2519-2520.Keywords
This publication has 8 references indexed in Scilit:
- Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated MacrophagesCancer Research, 2013
- Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesisProceedings of the National Academy of Sciences, 2011
- Cells of origin in cancerNature, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Angiogenesis as a therapeutic targetNature, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- On the Origin of Cancer CellsScience, 1956